FRLN — Freeline Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-CF Industries Holdings, DXC Technology Co, Rackspace Technology
U.S. STOCKS ON THE MOVE-Tesla, Enlivex Therapeutics, Sesen Bio, Tecent Music, NanoVibronix
U.S. STOCKS ON THE MOVE-Tesla, Sesen Bio, Citigroup, JD.Com, Travere Therapeutics
Freeline Therapeutics down as CEO changes amid management shakeup
Freeline Therapeutics down on wider loss, names new CEO
Freeline Therapeutics Holdings PLC reports results for the quarter ended in June - Earnings Summary
Brief: Freeline Therapeutics Holdings Appoints Michael Parini As CEO
Syncona Limited - Freeline Reports Executive Change and Q2 Results
Freeline Therapeutics Holdings PLC expected to post a loss of 97 cents a share - Earnings Preview
Brief: Freeline Therapeutics Holdings PLC Reiterates Its Guidance Across Key Upcoming Milestones Before Year End 2021
NASDAQ RESUMED AT 03:02 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:52 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
Brief: Freeline Doses Second Patient Of Phase 1/2 Marvel-1 Clinical Trial For Fabry Disease
NASDAQ RESUMED AT 09:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Syncona Limited - Freeline reports Q1 results
Freeline Therapeutics Holdings PLC reports results for the quarter ended in March - Earnings Summary
Brief: Freeline Therapeutics Holdings Posts Quarterly Loss Per Share Of $0.98